Categories: News

Guidepoint Unveils AI Moderation: Accelerate Expert Insights at Enterprise Scale

NEW YORK, Oct. 22, 2025 /PRNewswire/ — Guidepoint, a leading global expert network, today announced the launch of AI Moderation, a groundbreaking solution for gathering critical insights at scale. By enabling clients to conduct expert interviews without attending live calls, AI Moderation is able to increase the breadth and depth of perspectives gathered more efficiently and faster than ever before.

- Advertisement -

Guidepoint’s AI Moderation enables clients to extract high value knowledge at scale:

- Advertisement -
  • Increase Team Efficiency – Conduct dozens of interviews simultaneously without logistical constraints of coordinating and attending live calls
  • Start immediately – Launch consultations to deliver insights within hours, not days
  • Go truly global – 24/7 availability across time zones and geographies
  • Standardize quality – Consistent prompts and structured interviews deliver quality at scale

“Speed and quality shouldn’t be tradeoffs,” said Albert Sebag, CEO at Guidepoint. “With AI Moderation, our clients capture more perspectives, more quickly, with a level of consistency that’s hard to achieve in traditional workflows. It rapidly becomes a force multiplier alongside our live 1-to-1 expert calls.”

- Advertisement -

AI Moderation plugs directly into Guidepoint’s ecosystem. Clients can seamlessly combine live interviews and AI Moderation within the same project, enhancing the speed and efficiency of research initiatives while maintaining the same rigorous compliance and quality expectations. They can then synthesize their findings via AskGP, Guidepoint’s conversational AI assistant, turning unstructured conversations into active intelligence in one integrated flow.

- Advertisement -

Guidepoint AI Moderation is already proven to provide value under real-world conditions. Guidepoint has successfully facilitated thousands of interviews for early-adopter clients in addition to producing “AI-Guided” transcripts for its own content Library, using the same AI interviewer solution now broadly available to clients.

- Advertisement -

For more information on how you can leverage AI Moderation, contact a Guidepoint representative at sales@guidepoint.com.

- Advertisement -

About Guidepoint

Guidepoint connects clients with vetted subject matter experts from its global professional network. Guidepoint’s broad range of services empowers clients to access new industries, get up to speed on trending topics, conduct in-depth exploration of critical subjects, and validate qualitative insights. Guidepoint’s multinational client base includes top consulting firms, hedge funds, private equity firms, and Fortune-ranked public companies.

- Advertisement -

For more information, visit www.guidepoint.com.

- Advertisement -

Related Links
http://www.guidepoint.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/165294/guidepoint_global_llc_logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/guidepoint-unveils-ai-moderation-accelerate-expert-insights-at-enterprise-scale-302591077.html

- Advertisement -

Recent Posts

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

2 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

3 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

3 hours ago

New TALVEY(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of…

3 hours ago

President Droupadi Murmu Confers Kirti Chakra on Chandigarh University Alumnus Major Arshdeep Singh Gill

"Chandigarh University not only provides quality education but also instills a spirit of patriotism," says…

5 hours ago

Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock

Bitmine's Board of Directors declares initial cash dividends on the Company's 9.50% Series A Perpetual…

7 hours ago